Independent financial research
Ideas worth revisiting.
Explore the Porter & Co. research archive—from free market commentary to previews of our subscriber research.
Get Porter’s Daily Journal free →Articles tagged “biotech”
View all articlesThe Last Biotech Bull Market You’ll Ever Need
Read articleWhy Big Pharma Might Be This Year’s Top Sector
Read articleAn Insider’s Guide To This Year’s Biggest Deal In Biotech
Read articleThe Tools Are Finally Here
Read articleTech Frontiers Update: Sagimet Biosciences
Read articleAre We In An AI Bubble?
Read articleDoubling Down On Two Favorites
Read articleManaging Risk, Earning Fortunes
Read articleRevisiting Medicine 3.0
Read articleChina’s AI Landlord
Read articleA Piggybank For Ethereum
Read articleSupercharged By AI
Read articlePrime Time
Read articleA Biotech Blue Chip
Read articleSell Alert: Iovance Biotherapeutics (Nasdaq: IOVA)
Read articleOur Negative-EV Basket, Part II
Read articleA Biotech Tipping Point
Read articleSell Alerts: TG Therapeutics (TGTX) and Humacyte (HUMA)
Read articleA Miracle Drug For A Dreadful Disease
Read articleThe Next MicroStrategy
Read articleSpare Parts For Humans
Read articleSell Alert: Sell Shares of uniQure (QURE)
Read articleTrump’s Inflation Triggers
Read article